This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignee: Revolution Medicines, Inc.. Active years: 2022-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2026
Title: Steven G. Ballmer: Innovator in Pharmaceutical Patents
Introduction
Steven G. Ballmer is a notable inventor based in Redwood City, CA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds. With a total of 2 patents, his work focuses on advancing medical science through novel chemical formulations.
Latest Patents
Ballmer's latest patents include crystalline solid forms of a SHP2 inhibitor, specifically {6-[(2-amino-3-chloropyridin-4-yl)sulfanyl]-3-[(3S,4S)-4-amino-3-methyl-2-oxa-8-azaspiro[4.5]decan-8-yl]-5-methylpyrazin-2-yl} methanol. These patents detail the process of preparing these solid forms and their pharmaceutical compositions, along with methods of use. The innovative nature of these compounds holds promise for future therapeutic applications.
Career Highlights
Steven G. Ballmer is currently associated with Revolution Medicines, Inc., where he continues to push the boundaries of pharmaceutical research. His expertise in the field has led to significant advancements in drug development and formulation.
Collaborations
One of his notable collaborators is Shaoling Li, with whom he has worked on various projects aimed at enhancing the efficacy of pharmaceutical compounds.
Conclusion
Steven G. Ballmer's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for innovative solutions in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile